Centrum 7/6  banner

Cardinal reaffirms fiscal 2024 non-GAAP EPS guidance and long-term targets amidst nonrenewal of OptumRx customer contracts

Cardinal reaffirms fiscal guidance and long-term targets amidst nonrenewal of OptumRx customer contracts

Cardinal reaffirms fiscal guidance and long-term targets amidst nonrenewal of OptumRx customer contracts

DUBLIN, Ohio — Cardinal Health announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35. Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and

PP_1170x120_10-25-21